Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are getting your very first injection into the eye (called an intravitreal injection) for a retinal eye condition
- You are mentally able to make your own decisions and can communicate clearly without difficulty
- You are willing to read and sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have had eye surgery in the past
- Even with glasses or contact lenses, the vision in your better eye is below a certain level of clarity (confirm with trial site)
- The eye being treated also has a specific type of glaucoma caused by abnormal blood vessel growth, known as neovascular glaucoma (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoyun Fang, MD., PhD, Second Affiliated Hospital, School of Medicine, Zhejiang University
Phone: + 86 13588411946
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate and area of subconjunctival hemorrhage
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.